PEG-rHuMGDF enhances mobilization of PBPCs

The fold increase in peripheral blood progenitor cells (PBPCs) from day 1 (baseline) to day 15 in patients treated with chemotherapy on day 1 followed by either granulocyte colony-stimulating factor (G-CSF) alone or in combination with PEG-rHuMGDF. PBPC mobilization was markedly enhanced by combination therapy with G-CSF and PEG-rHuMGDF.